Windtree Therapeutics Announces Large Reduction of Preferred Series C and D Shares Outstanding by Conversion and Redemption
Investors choose to redeem or convert the majority of Series C and Series D Preferred 99% of outstanding preferred series...
Day: July 29, 2025
LogicMark, Inc. to Announce Second Quarter 2025 Financial Results on August 12, 2025
LOUISVILLE, Ky., July 29, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (OTC: LGMK), a provider of emergency response systems, health communications...
New Imprivata Report: Hospitals Save an Average of $1.1M Annually with Shared Mobile Devices, But Most Still Lack a Formal Use Policy
Shared mobile devices deliver significant benefits to clinical workflows and patient care, but gaps in user experience, oversight, and policy...
AIM ImmunoTech Announces Pricing of $8.0 Million Public Offering
OCALA, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (the “Company”), today announced the pricing...
NewGen Announces Strategic Acquisition of Cytometry Technology and Assets to Support Planned U.S. Expansion
The new cytometry technology enhances accessibility, safety, and efficiency in sperm-sorting procedures The acquisition of 18 cell-sorting systems and associated...
Fifty 1 Labs, Inc. Hosts Successful Virtual Shareholder Teleconference, Showcasing AI-Driven Functional Medicine Strategy and World-Class Leadership
SEATTLE, July 29, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc. (OTC: FITY), a pioneer in AI-powered...
Cannabix Technologies Receives Notice of Allowance from CIPO for Contactless Breath Analysis Patent Application
VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the...
The International Myeloma Foundation Mourns the Loss of Accomplished Attorney and Longtime Board Member Benson Klein
STUDIO CITY, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announces with great sadness the...
CVRx to Present at the Canaccord Genuity 45th Annual Growth Conference
MINNEAPOLIS, July 29, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing,...
Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference
SEATTLE and VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty...
Quoin Pharmaceuticals Provides Product Portfolio Update
Lead Product, QRX003, Being Tested in Two Active Registrational Clinical Studies for Netherton Syndrome Across the U.S., Europe, and the...
Foundation Health to Bring AI-Powered Patient Communication to Intermountain Health’s Specialty Pharmacy Patients
Foundation Health’s PAIGE AI Will Streamline Operations and Enhance Care Experience for Intermountain Health’s 14,000 Specialty Pharmacy PatientsSAN FRANCISCO, July...
IMUNON to Hold Second Quarter 2025 Financial Results and Business Update Conference Call on Tuesday, August 5, 2025
LAWRENCEVILLE, N.J., July 29, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its...
Cedar Gate Data Finds Nearly 60% of New Mothers Miss Essential Postpartum Follow-Up Care
Nationwide analysis of commercially insured members shows missed appointments far exceed prior estimates, highlighting urgent gaps in maternal health accessGREENWICH,...
Branded Legacy, Inc. Signs Letter of Intent to Acquire Bio-Legacy Evaluative Group, Advancing Innovations in Intranasal Drug Delivery
Strategic Acquisition Positions Branded Legacy to Enter the Growing Naloxone and Vaccine Markets, Enhancing Shareholder Value; Leadership Transition Planned with...
Therini Bio Announces First Patient Dosed in Phase 1b Trial of THN391 in Alzheimer’s Disease
- Pioneering approach to halting the chronic neuroinflammation responsible for neurodegeneration- Trial to assess safety, PK and detect early signs...
ProPhase Labs Announces Special Meeting of Shareholders and Filing of Preliminary Proxy Statement
Proxy Sets Company on a Path to Attract the Optimal Crypto Treasury Strategy Increase in Authorized Shares to 1 Billion...
Daré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY™ Sildenafil Cream
A first-of-its-kind solution for women’s arousal in a proprietary topical formulation demonstrated to work where women need it most Targeted...
Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the 2025 World Conference on Lung Cancer
SYDNEY, AUSTRALIA, July 29, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage...
UroGen Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 7th, 2025
Conference Call and Webcast Scheduled for Thursday, August 7th, 2025, at 10:00 AM ET PRINCETON, N.J., July 29, 2025 (GLOBE...